- Home
- CELZ vs EDSA Comparison
CELZ vs EDSA Comparison
Compare CELZ & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- EDSA
- Stock Information
- Founded
- CELZ 1998
- EDSA 2015
- Country
- CELZ United States
- EDSA Canada
- Employees
- CELZ N/A
- EDSA N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- EDSA Health Care
- Exchange
- CELZ Nasdaq
- EDSA Nasdaq
- Market Cap
- CELZ 5.5M
- EDSA 6.2M
- IPO Year
- CELZ N/A
- EDSA N/A
- Fundamental
- Price
- CELZ $2.29
- EDSA $2.37
- Analyst Decision
- CELZ
- EDSA Strong Buy
- Analyst Count
- CELZ 0
- EDSA 1
- Target Price
- CELZ N/A
- EDSA $21.00
- AVG Volume (30 Days)
- CELZ 140.2K
- EDSA 32.2K
- Earning Date
- CELZ 05-09-2025
- EDSA 05-09-2025
- Dividend Yield
- CELZ N/A
- EDSA N/A
- EPS Growth
- CELZ N/A
- EDSA N/A
- EPS
- CELZ N/A
- EDSA N/A
- Revenue
- CELZ $11,000.00
- EDSA N/A
- Revenue This Year
- CELZ N/A
- EDSA N/A
- Revenue Next Year
- CELZ N/A
- EDSA N/A
- P/E Ratio
- CELZ N/A
- EDSA N/A
- Revenue Growth
- CELZ 22.22
- EDSA N/A
- 52 Week Low
- CELZ $1.92
- EDSA $1.55
- 52 Week High
- CELZ $6.90
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- CELZ 32.75
- EDSA 53.35
- Support Level
- CELZ $1.95
- EDSA $2.31
- Resistance Level
- CELZ $2.24
- EDSA $2.55
- Average True Range (ATR)
- CELZ 0.33
- EDSA 0.11
- MACD
- CELZ -0.07
- EDSA -0.02
- Stochastic Oscillator
- CELZ 5.63
- EDSA 48.28
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.